glp 1 and bone loss Effects of Glucagon-Like Peptide-1 receptor agonists on health in people living with obesity | Osteoporosis International GLP-1 Agonists and Orthopedic Surgery:

Some people taking semaglutide report feeling colder than usual

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy

Heres how GLP-1s work in a woman's body

As in adults, gastrointestinal adverse effects were commonly seen

The Wu administration is considering dropping GLP-1 coverage for weight loss for City of Boston employees due to skyrocketing health insurance costs that are straining the citys finances.

Multiple randomized controlled trials and meta-analyses in patients with type 2 diabetes and obesity demonstrate that GLP-1RA therapy either preserves or modestly increases bone mineral density (BMD) at key skeletal sites lumbar spine and hip, GLP-1RAs also favorably modulate bone turnover markers, increasing bone formation markers (P1NP, osteocalcin, bone-specific alkaline phosphatase) and reducing bone resorption markers (-CTX), suggesting a net positive or neutral effect on bone remodeling